Scholion.ai

Part D Formulary and Benefit Design as a Risk-Steering Mechanism

Dana P. Goldman, Geoffrey F. Joyce, William B. Vogt

American Economic Review · 2011 · Volume 101 · Issue 3

DOI: 10.1257/aer.101.3.382

Abstract

Medicare Part D relies upon drug plan competition. Plans have enormous scope to design benefits and to set premiums, but they may not charge differential premiums based on risk. We use the formulary and benefit design of all Medicare prescription drug plans and pharmacy claims data to construct a simulation model of out-of-pocket drug spending. We use this simulation model to examine individual incentives in Medicare Part D for adverse selection. We find that high drug users have much stronger incentives to enroll in generous plans than do low users, thus there is significant scope for adverse selection.

Keywords

Consumer Economics: Empirical Analysis, Asymmetric and Private Information, Health: Government Policy, Regulation, Public Health, Economics of the Elderly, Economics of the Handicapped, Non-labor Market Discrimination

Enable JavaScript for citation tools and additional paper interactions.